Query: container closure integrity study methodology
Correspondence from Medicines and Healthcare products Regulatory Agency regarding MHRA-2022-0088. Type: deficiency. Risk: medium. Category: Nonclinical.
Correspondence ID
COR-288
Type
deficiency
Application
Authority
Medicines and Healthcare products Regulatory Agency
Category
Nonclinical
Risk
Medium
Due Date
2025-03-05
Status
In Progress
Owner
James O'Brien
Created
2024-03-09
Correspondence Body
Dear MHRA Review Team,
With reference to application MHRA-2022-0088, we wish to address the following:
[Detailed response body regarding deficiency letter: missing stability data for 40°c condition]
We trust this information is satisfactory. Please do not hesitate to contact us for further clarification.
Kind regards,
KCL BioPharm Regulatory Affairs
Response Assembly
Draft Response Actions:
Response deadline: 2025-03-05 — Assign relevant content components from the dossier and compile a response package using the Content Assembly Workbench.